We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system.
The information on the following pages may be made available in the United States. By clicking on the link below, you agree that you are in the United States.
Newron is committed to providing reliable and transparent information about our business in an open and timely manner. This area contains investment and shareholder information, key financial data and presentations and webcasts.
